NU7441 (KU-57788)

Catalog No.S2638

NU7441 (KU-57788) Chemical Structure

Molecular Weight(MW): 413.49

NU7441 (KU-57788) is a highly potent and selective DNA-PK inhibitor with IC50 of 14 nM and also inhibits PI3K with IC50 of 5 μM in cell-free assays.

Size Price Stock Quantity  
USD 70 In stock
USD 120 In stock
USD 370 In stock
USD 970 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

5 Customer Reviews

  • (C) Microirradiation live-cell microscopy of U2OS cells stably expressing mEGFP-MacroD2 full-length construct and treated with KU55933 10 μM, VE-821 1 μM, NU7441 1 μM or DMSO. Scale bar, 10 μm.

    Nucleic Acids Res, 2017, 45(1):244-254. NU7441 (KU-57788) purchased from Selleck.

    Cells were treated with cisplatin under the following conditions: pretreatment with Nu7026 (Nu7026, 26) or Nu7441 (Nu7441, 41). Before DNA damage, wortmannin was applied at 100 nM for 30 min, Nu7026 at 10 uM for 1 h, Nu7441 at 1 uM for 1 h. Accompanying quantifications of the adjusted nucleolar EU fluorescence are shown. Each condition was normalized to cells treated with DMSO or indicated inhibitors without DNA damaging treatment. Two-way ANOVA was followed by Holm-Sidak's test for the comparison of cells with and without inhibitors. *, **, *** represent P ≤ 0.05, 0.01, 0.001, respectively.

    Nucleic Acids Res 2013 41(15), 7378-86. NU7441 (KU-57788) purchased from Selleck.

  • Confocal immunostaining of S2056 phosphorylation of DNA-PKcs following radiation in HEK 293T and p18CycE-expressing cells.

    Nucleic Acids Res 2013 41, 10157-69. NU7441 (KU-57788) purchased from Selleck.

    Validation of activity and specificity of chemical inhibitors of; ATM, ATR, and DNAPK. H460 cells were treated with 1 uM camptothecin (CPT) or 20 ug/ml bleomycin for 1 h in the presence of the indicated inhibitors: DNAPK-i1—NU7026, DNAPK-i2—NU7441. MSH6, fibrillarin, and tubulin were used as loading controls.Effects of DNAPK inhibitors on its autophosphorylation in bleomycin-treated cells.

    Toxicol Sci 2014 10.1093/toxsci/kfu207. NU7441 (KU-57788) purchased from Selleck.

  • After starved in serum-free medium for 24h,A549 cells incubated with the indicated concentrations of NU-7441 for 3h,followed by 20-minute stimolation of 100ng/ml EGF.

    Dr. Zhang of Tianjin Medical University. NU7441 (KU-57788) purchased from Selleck.

Purity & Quality Control

Choose Selective DNA-PK Inhibitors

Biological Activity

Description NU7441 (KU-57788) is a highly potent and selective DNA-PK inhibitor with IC50 of 14 nM and also inhibits PI3K with IC50 of 5 μM in cell-free assays.
Targets
DNA-PK [1]
(Cell-free assay)
14 nM
In vitro

NU7441 increases the persistence of γH2AX foci after ionizing radiation–induced or etoposide-induced DNA damage. NU7441 (0.5 μM or 1 μM) appreciably increases G2-M accumulation induced by ionizing radiation, etoposide, and doxorubicin in both SW620 and LoVo cells. [2] NU7441 causes persistence of doxorubicin- and ionising radiation-induced DNA double-strand break and also slightly decreases homologous recombination activity DNA-PK-proficient M059-Fus-1 and DNA-PK-deficient M059 J human tumour cells. [3] NU7441 inhibits UV-induced RPA p34 hyperphosphorylation in a dose-dependent manner both in cells lacking and cells expressing polymerase η. [4] NU7441 increases levels of fludarabine-induced γH2AX foci and correspondingly decreased fludarabine-induced cell death in chronic lymphocytic leukemia cells. [5] NU7441 also inhibits mitoxantrone-induced DNA-PKcs autophosphorylation and repair in chronic lymphocytic leukemia cells. [6]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
NCI-H1770 NGizdXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmDhTWM2OD1yLkCyNVQ{KM7:TR?= NYXSZ2x{W0GQR1XS
A172 NXTK[XZIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXvCTZg5UUN3ME2wMlE2OzF4IN88US=> NHXhepFUSU6JRWK=
NCI-H526 NXLGfWN5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NG[yW2FKSzVyPUCuNlg1ODdizszN M4fZWXNCVkeHUh?=
HDLM-2 NWfJO4tIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1zMcmlEPTB;MD6zNlM1PSEQvF2= M{DKTnNCVkeHUh?=
HuO-3N1 MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlfyTWM2OD1yLkS2OlM3KM7:TR?= MljrV2FPT0WU
NCI-SNU-1 NYj4W|doT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUjaTFZXUUN3ME2wMlYxQTl2IN88US=> NEe5TIlUSU6JRWK=
SK-N-AS MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{f5R2lEPTB;MD62NlIyPiEQvF2= NYi1[pdMW0GQR1XS
LoVo MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mkj0TWM2OD1yLki2O|Q6KM7:TR?= NIrwfIxUSU6JRWK=
LAMA-84 NUXQZpp4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2DL[GlEPTB;MD65PFg{OyEQvF2= NHvQV4FUSU6JRWK=
CTB-1 MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NU\FZVZ4UUN3ME2xMlEyPTR4IN88US=> NH60O3hUSU6JRWK=
KP-N-YS NVvxVHo1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmnrTWM2OD1zLkG0NlMyKM7:TR?= M1fOTHNCVkeHUh?=
HH MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUXJR|UxRTFwMUiwPVMh|ryP NVrEeJhFW0GQR1XS
CHL-1 M3f3UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEDBdFlKSzVyPUGuNlE{PjhizszN NWPnZ5pnW0GQR1XS
NB7 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{nOWWlEPTB;MT6yOFc1PSEQvF2= NXLWOnFGW0GQR1XS
HL-60 M3PEVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnrRTWM2OD1zLkO4NVkh|ryP M1\mS3NCVkeHUh?=
639-V MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYXJR|UxRTFwNESxNlgh|ryP MY\TRW5ITVJ?
NCI-H1793 NHHFSFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXvodm1KUUN3ME2xMlQ2QDRizszN NIL1e3pUSU6JRWK=
NEC8 NH7YT4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEnOVo9KSzVyPUGuOVU{PSEQvF2= MVfTRW5ITVJ?
PA-1 NUXSNIxGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn;3TWM2OD1zLkW4Nlk1KM7:TR?= MVXTRW5ITVJ?
D-423MG NWfZW3Z3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHPDV4dKSzVyPUGuOlk{PjFizszN NULwPIdvW0GQR1XS
NCI-H292 MmK5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFLkS2FKSzVyPUGuO|QxOTNizszN NHPDbJZUSU6JRWK=
SK-MEL-1 NH7HdJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFvTNItKSzVyPUGuO|k1PzlizszN NE\2S3RUSU6JRWK=
LB2241-RCC M2TqXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmS1TWM2OD1{LkG0NVQ3KM7:TR?= MnzSV2FPT0WU
SK-MEL-3 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1jUVWlEPTB;Mj6xOlQ6KM7:TR?= M4LudnNCVkeHUh?=
MHH-PREB-1 NWfVPGxuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWjJR|UxRTJwMU[2NFkh|ryP NVHYZ3Q5W0GQR1XS
BFTC-905 NHGxfZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{HQdGlEPTB;Mj6xOlY5PyEQvF2= Mmr5V2FPT0WU
Ramos-2G6-4C10 M1Hp[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MW\JR|UxRTJwMUm5NFkh|ryP NYT5ZXY2W0GQR1XS
G-361 NU\5TplYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2PDNmlEPTB;Mj6yNVY5KM7:TR?= M3fsPXNCVkeHUh?=
MOLT-4 NHPl[XNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWLrVmdMUUN3ME2yMlIyQDh6IN88US=> MVfTRW5ITVJ?
DEL NETzTWJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NY[xTnhXUUN3ME2yMlM2PTZ2IN88US=> MonYV2FPT0WU
MV-4-11 NXPTcHc3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4rm[mlEPTB;Mj6zO|M6KM7:TR?= NInvPXdUSU6JRWK=
SK-NEP-1 Ml\ZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2X0NmlEPTB;Mj6zPFc5OyEQvF2= M{POe3NCVkeHUh?=
RS4-11 MknXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV[wZWlxUUN3ME2yMlU3ODJ|IN88US=> NYThU5ZEW0GQR1XS
HuH-7 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGXvblBKSzVyPUKuOVY4ODJizszN M2fqUXNCVkeHUh?=
A101D NV:1NmplT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NY\jNZZ6UUN3ME2yMlYyOzN6IN88US=> MXfTRW5ITVJ?
KG-1 M{fEVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVn3SWRlUUN3ME2yMlY4QTJ2IN88US=> NGH5S3dUSU6JRWK=
KALS-1 NGO3fINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnPjTWM2OD1{Lk[5OlM{KM7:TR?= NXnNeWg4W0GQR1XS
VMRC-RCZ MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MorMTWM2OD1{Lke3N|I5KM7:TR?= NW[5fpJOW0GQR1XS
SK-UT-1 NGjFZopIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF7SVWJKSzVyPUOuNVU{OSEQvF2= MnfGV2FPT0WU
SW962 NI\XXW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYXnWVlFUUN3ME2zMlIxOzV{IN88US=> NHi1TGtUSU6JRWK=
DBTRG-05MG NHzoO4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3TwNmlEPTB;Mz6yPFA5PSEQvF2= M2mxR3NCVkeHUh?=
PANC-08-13 MkH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWjJR|UxRTNwNEGyO|gh|ryP MlTDV2FPT0WU
QIMR-WIL M1;wSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmXGTWM2OD1|LkSxN|QyKM7:TR?= NVn4TnhlW0GQR1XS
SK-MEL-30 M3HGdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mne4TWM2OD1|LkSyOVk5KM7:TR?= M3LjPHNCVkeHUh?=
697 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1vqbWlEPTB;Mz60OFk6OyEQvF2= M4\KVHNCVkeHUh?=
NY NWHD[FNLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MY\JR|UxRTNwNEWwNlIh|ryP NF3n[XpUSU6JRWK=
ES7 NH\0O21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUnJR|UxRTNwNE[3Nlkh|ryP MUnTRW5ITVJ?
JVM-3 NF;xeYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlzhTWM2OD1|LkS4NFc4KM7:TR?= NXHsd2VuW0GQR1XS
U031 MorWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnnOTWM2OD1|LkW5N|Y5KM7:TR?= MknsV2FPT0WU
BHT-101 NGjKXIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{LJWmlEPTB;Mz61PVk5PSEQvF2= MmPuV2FPT0WU
8305C MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4\sdGlEPTB;Mz62NVc{PiEQvF2= NYjnSox[W0GQR1XS
MG-63 M3;hWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYPJR|UxRTNwNkK2O|Yh|ryP MmnrV2FPT0WU
NOS-1 M{n0Xmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHT2eXdKSzVyPUOuOlU{OTJizszN MWTTRW5ITVJ?
YH-13 NUjDbZVNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmrWTWM2OD1|Lki3NVg6KM7:TR?= NG\NWpJUSU6JRWK=
LXF-289 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1ThT2lEPTB;Mz65NVA1OSEQvF2= NIPOU2pUSU6JRWK=
GOTO NGLW[mhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYPJR|UxRTNwOUG0PUDPxE1? M4DzPHNCVkeHUh?=
EKVX NGG0fHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYXJR|UxRTRwMkK1NlQh|ryP NGrkXplUSU6JRWK=
CAL-51 M2PFc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{jqdWlEPTB;ND6yOFg2PCEQvF2= M3nwOHNCVkeHUh?=
AN3-CA MoTrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXq3c2U{UUN3ME20MlI2QDF|IN88US=> M4q5W3NCVkeHUh?=
IA-LM MkHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVzMRlF6UUN3ME20MlI4QTN3IN88US=> MlrtV2FPT0WU
KU-19-19 NHLINWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWnJR|UxRTRwM{K5NlEh|ryP MYHTRW5ITVJ?
A704 NHX0Nm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWrJR|UxRTRwNEC4PFgh|ryP M3viOnNCVkeHUh?=
RH-18 NIW3UWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUmwN5VDUUN3ME20MlQ1QTV|IN88US=> M3nFXHNCVkeHUh?=
IST-MEL1 MlH1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVjJR|UxRTRwNUiyOlMh|ryP NVO5NFgxW0GQR1XS
LU-134-A NFm0VIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYjJR|UxRTRwNUm2PFUh|ryP M{DMNHNCVkeHUh?=
SF126 NEGxUnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkTHTWM2OD12Lk[wO|E2KM7:TR?= M1XnWXNCVkeHUh?=
EFO-27 M2nBVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWrJR|UxRTRwNk[1NlUh|ryP MU\TRW5ITVJ?
SN12C MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NU\tWngzUUN3ME20MlcyQDl6IN88US=> MYLTRW5ITVJ?
L-363 NVzRPGVST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnnmTWM2OD12Lke3NVE3KM7:TR?= MVPTRW5ITVJ?
MEL-HO MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGXNenlKSzVyPUSuO|c6QDlizszN MkO4V2FPT0WU
TYK-nu MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYDJR|UxRTRwOECxNlgh|ryP NEOzZ2dUSU6JRWK=
MDA-MB-415 Mk\hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUfJR|UxRTVwMECzNVQh|ryP NGPkVGNUSU6JRWK=
HCC70 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkDvTWM2OD13LkCzPVM6KM7:TR?= M3XrdXNCVkeHUh?=
IGROV-1 M2T4NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIS3VnhKSzVyPUWuNlUzQTJizszN MnP1V2FPT0WU
NCI-H1355 NV3QZolVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml75TWM2OD13LkK5OkDPxE1? NX7BNJUxW0GQR1XS
23132-87 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIfDNXJKSzVyPUWuN|IxOjRizszN NWTvOJE1W0GQR1XS
NB69 NEHo[o9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2fiZmlEPTB;NT6zNlQzKM7:TR?= MoXwV2FPT0WU
HSC-2 NVG2dZl{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWTJR|UxRTVwNEG3O|Mh|ryP NX\pcoRQW0GQR1XS
KYSE-410 NX:xT5U6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYjRcHVZUUN3ME21MlQ4PjN4IN88US=> NV[4dYh[W0GQR1XS
GCIY Ml36S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3npXmlEPTB;NT61NVM4QCEQvF2= Mn\uV2FPT0WU
A427 M4XCWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUHJR|UxRTVwNUO2OlEh|ryP NWrMSWc{W0GQR1XS
ChaGo-K-1 MnfhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mlm1TWM2OD13LkW2OVk6KM7:TR?= MlHnV2FPT0WU
PFSK-1 NIK0OGlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NY\LOHV6UUN3ME21MlYzOTl2IN88US=> M1fQXHNCVkeHUh?=
MLMA MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{XENmlEPTB;NT64N|YxPiEQvF2= NEi2XG9USU6JRWK=
RVH-421 MkjwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MULJR|UxRTZwMEezN|gh|ryP NWnSTG57W0GQR1XS
LB1047-RCC MkLNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV7JR|UxRTZwMUe1NlIh|ryP M2e5VHNCVkeHUh?=
MHH-NB-11 M3fWSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUfVWlNFUUN3ME22MlMzPzJzIN88US=> NFnaR2NUSU6JRWK=
J-RT3-T3-5 M1TuZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV3VPYhPUUN3ME22MlY{OjlzIN88US=> NUjVeYdHW0GQR1XS
UM-UC-3 NIexeFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWTJR|UxRTZwNkSzN|Qh|ryP NWTneHE{W0GQR1XS
IST-SL1 NELadW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4PnOWlEPTB;Nj62PVM3QSEQvF2= M4PSfXNCVkeHUh?=
NB14 NXjYZoxJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M13zRmlEPTB;Nj63PVc3OSEQvF2= NH3GNHRUSU6JRWK=
NBsusSR M{G4bmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4qxOWlEPTB;Nj64NlUxOiEQvF2= NGro[GdUSU6JRWK=
D-263MG MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoT2TWM2OD14LkmxNFY5KM7:TR?= MX;TRW5ITVJ?
NCI-H2347 NVLvUXQ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV\oPHBzUUN3ME22Mlk{OjF|IN88US=> NIfyd3lUSU6JRWK=
ES8 NWTLbY9LT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXX6XXFyUUN3ME22Mlk4PTh6IN88US=> NGTxRYVUSU6JRWK=
786-0 M4PY[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlTTTWM2OD15LkC5O|g3KM7:TR?= MVLTRW5ITVJ?
EPLC-272H NEm5c|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlvITWM2OD15LkG2NlQ3KM7:TR?= M4jYSnNCVkeHUh?=
CAPAN-1 Ml7YS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXnJR|UxRTdwMkSzOVkh|ryP NFPtSGxUSU6JRWK=
NCI-H82 NWO1d2loT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlLvTWM2OD15LkK2OlU6KM7:TR?= M1\lRnNCVkeHUh?=
G-402 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYHFRWFQUUN3ME23MlMxODVzIN88US=> MnrHV2FPT0WU
SW982 M{H0cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUXSXo9DUUN3ME23MlMxOjB|IN88US=> NIe0bZNUSU6JRWK=
OVCAR-4 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M37jUGlEPTB;Nz6zNVMzQCEQvF2= MYrTRW5ITVJ?
KARPAS-299 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmDuTWM2OD15LkOyOlIzKM7:TR?= M4fZXHNCVkeHUh?=
MIA-PaCa-2 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXi4UGRVUUN3ME23MlM3QDJ|IN88US=> NXvae3FzW0GQR1XS
AU565 NWjJbldxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHLrb2JKSzVyPUeuOVk5OzNizszN NV;aNIFjW0GQR1XS
GAMG MmnxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MY\JR|UxRTdwNkSxN|Eh|ryP NYLGVodOW0GQR1XS
HuO9 M{D0dGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGrlO3dKSzVyPUeuO|E4PDNizszN Ml\vV2FPT0WU
ACN MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoraTWM2OD15Lke0N|Mh|ryP NFLkWWJUSU6JRWK=
RO82-W-1 MoTnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYruTVJLUUN3ME23Mlc1PTN|IN88US=> MlPQV2FPT0WU
NKM-1 NWrlTol7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3HFemlEPTB;Nz63OFk2PSEQvF2= M2fPS3NCVkeHUh?=
CAL-12T NXu2eXp5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUmwcWt6UUN3ME23Mlk1OzV{IN88US=> NV;nb2l5W0GQR1XS
FADU M1LLT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mly5TWM2OD16LkCzOlU1KM7:TR?= NHrtPZZUSU6JRWK=
NCI-H28 MkWzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{OxZWlEPTB;OD6xOlk3OiEQvF2= MUTTRW5ITVJ?
LCLC-97TM1 MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2j3bWlEPTB;OD6yNVEzOiEQvF2= M2fVTnNCVkeHUh?=
CHP-134 NHPqTG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFe5NHVKSzVyPUiuNlQyQDVizszN M32zTnNCVkeHUh?=
HT-1080 M{ThVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2j0bWlEPTB;OD6yOVA6OyEQvF2= M3rSd3NCVkeHUh?=
PC-3 NXy4W3ZOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGixNGtKSzVyPUiuNlc{QTJizszN NGfGNGdUSU6JRWK=
SNU-449 MnvTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkPYTWM2OD16LkK3PVMh|ryP Mo\LV2FPT0WU
VA-ES-BJ MoTGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUnJR|UxRThwM{S2PFYh|ryP MYnTRW5ITVJ?
HT M4myO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnTNTWM2OD16LkO2OFkh|ryP NULrW3VEW0GQR1XS
HOS NXe4VFduT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1nJXWlEPTB;OD6zO|U5QSEQvF2= NUnZVZBzW0GQR1XS
KNS-62 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MorXTWM2OD16LkO3O|YzKM7:TR?= M2PDOHNCVkeHUh?=
OAW-42 NFTmbpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWDJR|UxRThwOUW5OlQh|ryP NU\4enpTW0GQR1XS
A549 M1S1Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV\JR|UxRTlwMEm2NVIh|ryP NVrPZXVlW0GQR1XS
CAKI-1 NHPWZ3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYLxVHExUUN3ME25MlE3PjFizszN MkfkV2FPT0WU
HCC1937 NWfzdlBDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWPJR|UxRTlwNkm4OlUh|ryP NGHveZdUSU6JRWK=
GI-ME-N M3iyOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIPYO5JKSzVyPUmuO|AyOzdizszN MoHlV2FPT0WU
DU-4475 MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkPDTWM2OD17Lkm2PVM6KM7:TR?= M2rq[HNCVkeHUh?=
EM-2 MkPnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoTpTWM2OD1zMD6yOFI3KM7:TR?= M4naUHNCVkeHUh?=
NCI-H1755 M1m5Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MliyTWM2OD1zMD6yOFI5KM7:TR?= NID5dY9USU6JRWK=
NCI-H1437 MofWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIDRSoFKSzVyPUGwMlU4OjVizszN M13ienNCVkeHUh?=
VM-CUB-1 NHTkeHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1iyXmlEPTB;MUCuOlE3PCEQvF2= MY\TRW5ITVJ?
A2058 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmHhTWM2OD1zMD62OFA1KM7:TR?= MXPTRW5ITVJ?
BPH-1 NIfLSW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkjnTWM2OD1zMD63NVQ2KM7:TR?= MULTRW5ITVJ?
NB5 Ml32S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmW4TWM2OD1zMD63OVU6KM7:TR?= MWDTRW5ITVJ?
G-401 NFL0OJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnzUTWM2OD1zMD63OlI3KM7:TR?= NVfEO3Q5W0GQR1XS
CAL-72 M4H1d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVvJR|UxRTFyLkiwPVQh|ryP NXewdXhOW0GQR1XS
SK-MEL-28 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHLScItKSzVyPUGwMlgzODJizszN NEXLcXdUSU6JRWK=
C32 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NF3MUINKSzVyPUGwMlg{PDdizszN NIrUcY5USU6JRWK=
NCI-H1155 NEf0dGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHrHTXlKSzVyPUGwMlg{PzZizszN NXrpdWZ6W0GQR1XS
BB49-HNC NV76[nBjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF72[5pKSzVyPUGwMlg2QDZizszN NF3CRWpUSU6JRWK=
GMS-10 M37jSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmjnTWM2OD1zMD64PVcyKM7:TR?= MVfTRW5ITVJ?
K5 Ml;tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3mxOWlEPTB;MUCuPVA4OSEQvF2= MXnTRW5ITVJ?
OS-RC-2 M1W4[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXvJR|UxRTFzLkC1OVkh|ryP NEfGS2xUSU6JRWK=
HTC-C3 M3nRZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYnJR|UxRTFzLkC3NVQh|ryP NHj4XJVUSU6JRWK=
LB996-RCC NXHGeG5QT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWCzbY5IUUN3ME2xNU4xPzJ|IN88US=> NXPjO|Z4W0GQR1XS
NCI-H1563 M1jBb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUjFTJFoUUN3ME2xNU4yODFzIN88US=> NVvVe4c6W0GQR1XS
CAL-54 M1yzcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4i5eWlEPTB;MUGuOFgyOSEQvF2= M3TueHNCVkeHUh?=
WM-115 NV75b2VVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1eycWlEPTB;MUGuOlgzPCEQvF2= MofaV2FPT0WU
COLO-684 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFfqc25KSzVyPUGxMlczPjdizszN MXHTRW5ITVJ?
HOP-62 MoT1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFSwVZRKSzVyPUGxMlc2ODhizszN M2rJO3NCVkeHUh?=
NCI-H650 M33BeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWe3b215UUN3ME2xNU45QTZzIN88US=> MmGwV2FPT0WU
TE-11 NH7zRYlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWnoTFBmUUN3ME2xNU46OzF3IN88US=> NGXifGhUSU6JRWK=
COLO-679 M1qw[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHrjR2hKSzVyPUGxMlk1PiEQvF2= NGez[WdUSU6JRWK=
FTC-133 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHLZZXZKSzVyPUGyMlAxPzZizszN MUfTRW5ITVJ?
D-283MED NEnq[pBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYHObXQ1UUN3ME2xNk4xPTZ7IN88US=> NUjzeWZrW0GQR1XS
SK-PN-DW Mn7tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWTwXVVSUUN3ME2xNk4yQTB{IN88US=> MnXiV2FPT0WU
BALL-1 NYTNO|NDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWm2SlhUUUN3ME2xNk4zPjZ{IN88US=> MUDTRW5ITVJ?
GT3TKB NGjTfXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF;lfHpKSzVyPUGyMlMxPzRizszN NVT5NlNMW0GQR1XS
HOP-92 NY\4N4l[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX3JR|UxRTF{LkWyN|Mh|ryP NV:2dpF4W0GQR1XS
M14 M33mZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXnJR|UxRTF|LkCzN|Uh|ryP NHzmOWZUSU6JRWK=
SKG-IIIa Ml3aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEPSeVVKSzVyPUGzMlA2PTRizszN M{HVZ3NCVkeHUh?=
Becker M2\ReGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWHJR|UxRTF|LkC1PEDPxE1? MXTTRW5ITVJ?
ES5 NVnVcIZ[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXLJR|UxRTF|LkGzOVYh|ryP M13tc3NCVkeHUh?=
NCI-H2030 Mkf2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3jTSGlEPTB;MUOuNlA3OiEQvF2= NXr3WIl6W0GQR1XS
SNU-423 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVX4XmYyUUN3ME2xN{4{QDFizszN MoH6V2FPT0WU
CP50-MEL-B MlnYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MorVTWM2OD1zMz62NlMzKM7:TR?= NWrIWWFvW0GQR1XS
NCI-H1092 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlTGTWM2OD1zMz63OFc2KM7:TR?= NVO5blI4W0GQR1XS
8-MG-BA Mkn3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MU\JR|UxRTF|Lke1NVMh|ryP M37nd3NCVkeHUh?=
CAL-27 M3;Jdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M37JdGlEPTB;MUSuNFczPyEQvF2= NXqxU4lLW0GQR1XS
AGS MoO1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFXrVJhKSzVyPUG0MlE{OTlizszN NHu1U3lUSU6JRWK=
MZ2-MEL NIDY[ppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYG4WWNkUUN3ME2xOE4yPDh6IN88US=> NUXBUWw1W0GQR1XS
BFTC-909 M4rpb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVXJR|UxRTF2LkWwOVUh|ryP M4rUT3NCVkeHUh?=
D-566MG M3XVNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmPFTWM2OD1zND63O|A3KM7:TR?= NEfwXI1USU6JRWK=
MZ7-mel NH6wXYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV\JR|UxRTF3LkGwOlch|ryP MYTTRW5ITVJ?
TE-5 NYrZd41GT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHHQWopKSzVyPUG1MlI{OzNizszN NFu4SYNUSU6JRWK=
647-V NEHB[ZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnTGTWM2OD1zNT6yO|A2KM7:TR?= M1O0eHNCVkeHUh?=
DMS-114 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NITD[5NKSzVyPUG1MlMzQTFizszN NHHIUnpUSU6JRWK=
ME-180 M4\hUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoLzTWM2OD1zNT60O|g{KM7:TR?= MY\TRW5ITVJ?
MS-1 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnPXTWM2OD1zNT61OlI{KM7:TR?= MnPZV2FPT0WU
NUGC-3 M{H3XWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWTJR|UxRTF3Lk[yOFUh|ryP NIXWcYFUSU6JRWK=
GB-1 MorsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2X1[WlEPTB;MUWuOlQ{PyEQvF2= MlXXV2FPT0WU
LOXIMVI MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlmyTWM2OD1zNT64PVE6KM7:TR?= MlnvV2FPT0WU
NCI-H1304 MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUfqPJA3UUN3ME2xOU45QTJ6IN88US=> M{HHNnNCVkeHUh?=
KURAMOCHI NVG5WoF3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1z1TWlEPTB;MUWuPVcyKM7:TR?= MlW1V2FPT0WU
SW1783 MmPQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVHhXIh4UUN3ME2xOk4xQTl|IN88US=> MkP5V2FPT0WU
EGI-1 NGnTcY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1zM[mlEPTB;MU[uOVM3PSEQvF2= NXHrc2E{W0GQR1XS
KGN NU\VSnpDT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUTtZopyUUN3ME2xOk42PTh4IN88US=> M1nqbHNCVkeHUh?=
PANC-03-27 NH7nR45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVnJR|UxRTF4Lke2OlIh|ryP NWnGcpZTW0GQR1XS
RH-1 M1fKd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn7nTWM2OD1zNj64NlUh|ryP MWHTRW5ITVJ?
HT-1376 NHHjfGVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnHGTWM2OD1zNj64OFQ3KM7:TR?= Mk[5V2FPT0WU
ZR-75-30 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXfYdWFuUUN3ME2xOk46OzZzIN88US=> NVHvNlV6W0GQR1XS
TI-73 NVTj[5IxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlvpTWM2OD1zNj65OFA5KM7:TR?= NHLB[29USU6JRWK=
TK10 M3fJfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXvJR|UxRTF5LkCwO|kh|ryP Ml3OV2FPT0WU
SW684 NH7xOoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MW\JR|UxRTF5LkCxOVQh|ryP MWfTRW5ITVJ?
RPMI-8866 NVPiUpgzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkDqTWM2OD1zNz6wOlk6KM7:TR?= MXfTRW5ITVJ?
LNCaP-Clone-FGC NFLaW5pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYXJR|UxRTF5LkWyNFEh|ryP NGnBc2JUSU6JRWK=
NCI-H2291 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVzXPWxIUUN3ME2xPE41OzR3IN88US=> MXfTRW5ITVJ?
T47D NX7sToVUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnfKTWM2OD1zOD60PFgh|ryP MXPTRW5ITVJ?
A204 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlW4TWM2OD1zOD61OFUzKM7:TR?= NHjVW|RUSU6JRWK=
HT-144 MoXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF;K[oFKSzVyPUG4Mlc1OjdizszN NFPwPFFUSU6JRWK=
MDA-MB-361 MofaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEj1bGtKSzVyPUG5MlA4OTRizszN NE\IfIxUSU6JRWK=
HCC1806 NEfp[mZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3XoWGlEPTB;MUmuNVU6OSEQvF2= NGHkdWRUSU6JRWK=
NCI-H596 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NW\nNGZpUUN3ME2xPU43OzlzIN88US=> NGjEc3NUSU6JRWK=
K-562 NEXXdoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIDKbIhKSzVyPUG5Mlg6OjZizszN MXLTRW5ITVJ?
D-336MG MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mni2TWM2OD1zOT65N|IzKM7:TR?= NFPhbYpUSU6JRWK=
SK-MEL-2 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGf0W4JKSzVyPUKwMlE2PTlizszN MV3TRW5ITVJ?
HEC-1 NVXFTVNsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4ToW2lEPTB;MkCuOFk4QCEQvF2= MW\TRW5ITVJ?
EW-13 M2XMSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFy4bGtKSzVyPUKwMlU1PDNizszN NWX2WnIxW0GQR1XS
Hs-578-T Mk[3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF\VR3NKSzVyPUKwMlU2QDNizszN MYTTRW5ITVJ?
SJSA-1 M4PiZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXzaVoduUUN3ME2yNE42Pjh6IN88US=> NY\JUmpIW0GQR1XS
RCC10RGB Mmn2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{nEbmlEPTB;MkCuOlcyQSEQvF2= MljLV2FPT0WU
LAN-6 MnPkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFfyeJJKSzVyPUKxMlA{QTZizszN M{H2fHNCVkeHUh?=
NCI-H1048 NVHMNGJHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NY[0XFh4UUN3ME2yNU4zOjV6IN88US=> M{i3dXNCVkeHUh?=
CW-2 M4DlZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2HoNmlEPTB;MkGuNlcxPSEQvF2= MkLaV2FPT0WU
HCC2157 M3;pbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnzkTWM2OD1{MT6zOkDPxE1? NVTNVYR{W0GQR1XS
EW-22 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWSySW9QUUN3ME2yNU4{PzZizszN NXXHb2l{W0GQR1XS
A253 Mo[yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXPJR|UxRTJzLkS0PFEh|ryP NHS2XIZUSU6JRWK=
BE-13 M{\Ne2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWjzdY9mUUN3ME2yNU43OTF|IN88US=> MW\TRW5ITVJ?
KINGS-1 MknJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NY\hfWRGUUN3ME2yNU43OzF4IN88US=> MmmxV2FPT0WU
ETK-1 M{nOd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{PLTWlEPTB;MkGuPFE2OiEQvF2= NFPU[ZlUSU6JRWK=
NCI-H2452 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYHzV|c4UUN3ME2yNU45PjR5IN88US=> MWLTRW5ITVJ?
HPAF-II MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlL3TWM2OD1{MT64PVI{KM7:TR?= MXTTRW5ITVJ?
D-542MG NHfERoVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NID2SZFKSzVyPUKxMlkxPjlizszN MVrTRW5ITVJ?
NCI-H630 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mkm0TWM2OD1{Mj6wNlk3KM7:TR?= MX3TRW5ITVJ?
TGBC11TKB M2\IbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXL2S|BFUUN3ME2yNk4xPDlizszN MkLOV2FPT0WU
BCPAP M1HPUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUX0WIxPUUN3ME2yNk43OTFizszN MmK2V2FPT0WU
HLE NIDWfVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF\nW|BKSzVyPUKyMlY6PyEQvF2= M3rMOnNCVkeHUh?=
NCI-H727 NUXHUodlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFXMUHlKSzVyPUKyMlc{PSEQvF2= NXzON4J{W0GQR1XS
RD M{nxVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVTDWppJUUN3ME2yNk44PTF6IN88US=> NXnX[5dRW0GQR1XS
NCI-H522 M4fM[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MV;JR|UxRTJ{Lki0N|Eh|ryP NFXwVJdUSU6JRWK=
CGTH-W-1 NIPKTm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGTNdotKSzVyPUKzMlA3PDFizszN NWOzPYxVW0GQR1XS
SK-LU-1 NIGxR5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUjJR|UxRTJ|LkS2PFMh|ryP MVzTRW5ITVJ?
BB65-RCC NHXuXHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVHn[3hsUUN3ME2yN{44QDZ|IN88US=> NIfvUG1USU6JRWK=
HSC-3 NYfQbHBQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlLoTWM2OD1{Mz64OVI4KM7:TR?= NHPSeHpUSU6JRWK=
SK-MES-1 NXvkUI9KT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWL5WZBDUUN3ME2yOE4xOTZzIN88US=> MYfTRW5ITVJ?
DB NHTrXoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXfJR|UxRTJ2LkGwNlgh|ryP NGHCN|lUSU6JRWK=
HO-1-N-1 M2jlcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MljWTWM2OD1{ND6zNFk{KM7:TR?= MWPTRW5ITVJ?
MKN1 MmLKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXvJR|UxRTJ2Lk[4JO69VQ>? M1zOdXNCVkeHUh?=
MN-60 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX\JR|UxRTJ2Lki1NVkh|ryP MV7TRW5ITVJ?
8505C MoT0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYXJR|UxRTJ3LkG4OFUh|ryP M{LnVnNCVkeHUh?=
COLO-320-HSR M332Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3vlPGlEPTB;MkWuNlIxQCEQvF2= MVvTRW5ITVJ?
BB30-HNC NIfMflRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2XTO2lEPTB;MkWuNlQ5OyEQvF2= NWPHS2tqW0GQR1XS
KM12 NGnidndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mk\KTWM2OD1{NT61PFA4KM7:TR?= NVjrc5B3W0GQR1XS
NB13 NHvFellIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlHiTWM2OD1{NT61PFk5KM7:TR?= NWfY[GF3W0GQR1XS
HCC2998 NWG0WpU5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoTqTWM2OD1{Nj6wNlg{KM7:TR?= NUPodWNsW0GQR1XS
U-118-MG MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH3rbZRKSzVyPUK2MlA5ODhizszN M{W2c3NCVkeHUh?=
NB10 MlrMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mk\4TWM2OD1{Nj6yN|Qh|ryP MWLTRW5ITVJ?
SK-LMS-1 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkLvTWM2OD1{Nz6wO|A1KM7:TR?= NXzPSodRW0GQR1XS
SW1573 MkK4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWXhe4hGUUN3ME2yO{4yOSEQvF2= MlqyV2FPT0WU
LB373-MEL-D NULWWZNvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIn5[2RKSzVyPUK3MlEzQTRizszN NY\HPVlMW0GQR1XS
DK-MG NIDuRplIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV7Mb296UUN3ME2yO{4yQDF5IN88US=> NWW4PJVbW0GQR1XS
RMG-I M{Xhfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnzjTWM2OD1{Nz6yNFI6KM7:TR?= NHXYWnhUSU6JRWK=
SW1088 MoHGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1PQUGlEPTB;MkeuOVA1OiEQvF2= NGK4NYRUSU6JRWK=
SK-OV-3 NYPtSZVoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIXHVlJKSzVyPUK3Mlc2QTNizszN MXnTRW5ITVJ?
KP-N-YN MoHXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlG4TWM2OD1{Nz64NFQ{KM7:TR?= NGfCeHBUSU6JRWK=
RPMI-7951 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGf2dmJKSzVyPUK4MlI1PTZizszN M2W3U3NCVkeHUh?=
CaR-1 M1nqOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlPMTWM2OD1{OD61OVgzKM7:TR?= M{X3eHNCVkeHUh?=
MKN7 NW\GZm54T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEmyS5lKSzVyPUK4MlU6PjRizszN NIDVN|hUSU6JRWK=
CHP-212 M2C1cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYrHUVBNUUN3ME2yPE44PDBzIN88US=> NVnJcYtEW0GQR1XS
KYSE-450 MmHYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkC5TWM2OD1{OD64NFkyKM7:TR?= Ml;PV2FPT0WU
RXF393 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVTab5VxUUN3ME2yPU4zQTB4IN88US=> NFnRZ4hUSU6JRWK=
P30-OHK MkjzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYnpfFZNUUN3ME2yPU4{ODR6IN88US=> MUXTRW5ITVJ?
Ca9-22 MkHwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml;FTWM2OD1{OT60Nlk6KM7:TR?= M2nyW3NCVkeHUh?=
RT-112 NXe5N2xtT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1rZNmlEPTB;MkmuOFYyOSEQvF2= NXjzZ4NSW0GQR1XS
ES1 MnPkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWnJR|UxRTJ7Lki1OFQh|ryP MmfNV2FPT0WU
HCE-4 NWDDbnNrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX;JR|UxRTJ7Lki3PFYh|ryP MlfJV2FPT0WU
AM-38 MkXJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MorqTWM2OD1|MD6wOlA3KM7:TR?= NUTOVm5kW0GQR1XS
AsPC-1 NXTpclJST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVrJR|UxRTNyLkiwOVMh|ryP MVrTRW5ITVJ?
TE-9 NYq1bHozT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mk\LTWM2OD1|MD64O|M4KM7:TR?= MXfTRW5ITVJ?
HuP-T4 NYnUUldIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MULJR|UxRTNyLkm2N|gh|ryP M4L5UnNCVkeHUh?=
LB2518-MEL M3vucGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXTJR|UxRTNzLkC3OFQh|ryP NEm5WotUSU6JRWK=
NCI-H1703 NGDqfHNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NI\rVmNKSzVyPUOxMlA6ODVizszN M3Hnc3NCVkeHUh?=
NCI-H2228 NYiyZZJET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{nLOGlEPTB;M{GuOFY2OSEQvF2= MkO3V2FPT0WU
SCC-4 NITQNG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn7WTWM2OD1|MT65NVgyKM7:TR?= MnvDV2FPT0WU
KNS-81-FD NH\wTHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1PVOGlEPTB;M{KuNFEzQCEQvF2= MlniV2FPT0WU
NTERA-S-cl-D1 MkLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYjCNGJkUUN3ME2zNk4xPzN7IN88US=> M2HkVHNCVkeHUh?=
Daoy MmW5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUTMcXN5UUN3ME2zNk4xQDN6IN88US=> NULMdplMW0GQR1XS
ES4 NEjSO4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHPKUGlKSzVyPUOyMlM6OjJizszN M4W2WHNCVkeHUh?=
MHH-ES-1 MmXyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXrKUGg6UUN3ME2zNk41QDd{IN88US=> MnvtV2FPT0WU
C-33-A MmDVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NX7mcow4UUN3ME2zNk44PzJ6IN88US=> NGrvdYNUSU6JRWK=
BHY MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3nXTGlEPTB;M{KuPVQ6PSEQvF2= M3XUPHNCVkeHUh?=
Detroit562 NV7M[5FuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MkXGTWM2OD1|Mz62OlU4KM7:TR?= Mk\CV2FPT0WU
EW-1 NGL0cJBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmPpTWM2OD1|Mz65N|IzKM7:TR?= M4HVe3NCVkeHUh?=
NCI-H1395 MnrDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkfrTWM2OD1|ND6wO|k6KM7:TR?= NEjwWGJUSU6JRWK=
KM-H2 M2PzOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHTiSHZKSzVyPUO2MlQ4PDNizszN MXrTRW5ITVJ?
NCI-H520 NFqzZ5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX\RNplbUUN3ME2zOk44PTRzIN88US=> MoS5V2FPT0WU
D-392MG MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2PLSGlEPTB;M{euN|M1PCEQvF2= M3jrTXNCVkeHUh?=
NOMO-1 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{nkPWlEPTB;M{euPFA5QSEQvF2= M2rNdnNCVkeHUh?=
TE-6 NInYS2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGTReppKSzVyPUO4MlEzPCEQvF2= M{PNcnNCVkeHUh?=
HT-3 M4PDOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX7JR|UxRTN6LkS0N|Yh|ryP MXvTRW5ITVJ?
RPMI-8226 NE[zUnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmfGTWM2OD1|OD65OVE6KM7:TR?= M4nuVHNCVkeHUh?=
U251 MkfOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYTJR|UxRTN7LkCxNlQh|ryP MmPoV2FPT0WU
GCT Mnr1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MofITWM2OD1|OT6xPFUzKM7:TR?= MVfTRW5ITVJ?
A431 M1Ln[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGXVSmtKSzVyPUO5MlE5QTRizszN MYXTRW5ITVJ?
TE-12 MkDDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIe3ZlNKSzVyPUO5MlI1PDhizszN MXHTRW5ITVJ?
HMV-II MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUDJV5FvUUN3ME2zPU42ODR5IN88US=> MnuzV2FPT0WU
IST-MES1 NHTzUo9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTRyLkG1NFIh|ryP Mn;FV2FPT0WU
SW13 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml7UTWM2OD12MD61NVkh|ryP M3XKenNCVkeHUh?=
SF295 M2HsU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NU\LVJZlUUN3ME20NE45ODZ4IN88US=> M4rhbXNCVkeHUh?=
MDA-MB-157 MkLmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXi5c296UUN3ME20NE46PDZ{IN88US=> NFnWfoxUSU6JRWK=
TE-1 NGjDWoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2jTW2lEPTB;NEGuPFcyPCEQvF2= NEnlfVZUSU6JRWK=
HuCCT1 Ml;iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2\VRWlEPTB;NEKuOVI5QSEQvF2= M4rCdHNCVkeHUh?=
KYSE-510 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV7RT3pnUUN3ME20N{4yPzV2IN88US=> MkDlV2FPT0WU
NCI-H358 MlzDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWfUSnRxUUN3ME20OE4xOzB2IN88US=> M13SPXNCVkeHUh?=
SW900 NVy4Z5pFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnHOTWM2OD12ND6wO|U5KM7:TR?= NFHzdYpUSU6JRWK=
CAS-1 NH[3SnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV3JR|UxRTR2LkC5PVEh|ryP M3HPZ3NCVkeHUh?=
TE-8 MkLmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{S4d2lEPTB;NESuOVY2QCEQvF2= NH7zZpFUSU6JRWK=
P12-ICHIKAWA MlPOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXOzcWxnUUN3ME20OE43OTF{IN88US=> NH;PWmtUSU6JRWK=
YKG-1 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml;TTWM2OD12ND63PFEh|ryP NYPBWXRQW0GQR1XS
SNU-C2B M2W0Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVzvRZVXUUN3ME20OE44QTB|IN88US=> MUnTRW5ITVJ?
LCLC-103H NEf4VFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnSyTWM2OD12ND64O|A{KM7:TR?= M4H0b3NCVkeHUh?=
U-87-MG MkTzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2fjZWlEPTB;NEWuNVAzOiEQvF2= MojHV2FPT0WU
HAL-01 M2HtVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2W2XmlEPTB;NEWuNVM4QSEQvF2= Ml\EV2FPT0WU
OVCAR-8 MkfMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXjJR|UxRTR3LkO1OlQh|ryP MlPYV2FPT0WU
KYSE-150 M{n4eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MkjGTWM2OD12Nz6xNFUzKM7:TR?= MkL1V2FPT0WU
OE33 NFjuSnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWDJR|UxRTR5LkG0Nlkh|ryP MmHqV2FPT0WU
CAL-62 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{[xXGlEPTB;NEeuOFA3QCEQvF2= NVG1XFllW0GQR1XS
TCCSUP MmXnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUjhd4JIUUN3ME20O{43OjZ2IN88US=> NX\ISY9XW0GQR1XS
H4 NGjBVIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M13kZWlEPTB;NEeuOlYzOSEQvF2= MoDqV2FPT0WU
CP66-MEL NIi3VVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MoPGTWM2OD12OD6wO|A1KM7:TR?= MkHHV2FPT0WU
SNB75 MkHGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYHNN5NvUUN3ME20PE4yQDd2IN88US=> NWXJS5dzW0GQR1XS
Mo-T MlPCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWjJR|UxRTR6LkK3PUDPxE1? M3XOVXNCVkeHUh?=
BT-549 NVe1dZNQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MY\JR|UxRTR6LkO3Nlkh|ryP NVvhe5BqW0GQR1XS
IGR-1 NG\yRmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlrQTWM2OD12OD62OlQ2KM7:TR?= NYK3UIo3W0GQR1XS
NCI-H1299 MoLpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Ml7MTWM2OD12OD63NlQ5KM7:TR?= NXvtVGJiW0GQR1XS
ALL-PO NEn5[G5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUW4enJIUUN3ME20PU46OjZ6IN88US=> M1GwWXNCVkeHUh?=

... Click to View More Cell Line Experimental Data

In vivo NU7441 intraperitoneally administrated at dose of 10 mg/kg maintains for at least 4 hours shows nontoxic and increases etoposide-induced tumor growth delay 2-fold in mice bearing SW620 xenografts. [2]

Protocol

Cell Research:[2]
+ Expand
  • Cell lines: SW620, LoVo, V3-YAC and V3 cells
  • Concentrations: 0.5 μM or 1 μM
  • Incubation Time: 17 hours
  • Method: The effect of NU7441 on cellular survival following exposure to etoposide, doxorubicin, and ionizing radiation is measured in SW620, LoVo, V3, and V3-YAC cells by clonogenic assays. Briefly, growing cells in six-well plates or 6-cm dishes are exposed to etoposide or doxorubicin with or without NU7441 (0.5 or 1.0 μM) for 16 hours. For radiosensitization studies, NU7441 is added to the cells 1 hour before irradiation. V3 and V3-YAC cells are exposed to γ-irradiation (3.1 Gy/min 137Cesium). SW620 and LoVo are exposed to X-irradiation (2.9 Gy/min at 230 kV, 10 mA) due to the equipment available. After irradiation, the cells are incubated with or without NU7441 for a further 16 hours. Cells are then harvested by trypsinization, counted, and seeded into 10-cm diameter Petri dishes at densities varying from 100 to 105 per dish in drug-free medium for colony formation. Colonies are stained with crystal violet after 10 to 14 days and counted with an automated colony counter. The survival reduction factor (SRF) is calculated as the surviving fraction of cells in the absence of NU7441 divided by the surviving fraction of cells in the presence of NU7441 for any given dose or concentration of cytotoxic agent. The dose modification ratio (DMR90) is calculated as the concentration/dose of cytotoxic agent required to kill 90% of the cells in the absence of NU7441 divided by the concentration/dose of cytotoxic agent required to kill 90% of the cells in the presence of NU7441.
    (Only for Reference)
Animal Research:[2]
+ Expand
  • Animal Models: Female rude mice bearing SW620 xenografts
  • Formulation: Sterile 0.9% sodium chloride solution
  • Dosages: 10 mg/kg
  • Administration: Intraperitoneally administrated
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 4 mg/mL warmed (9.67 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order:
4% DMSO+30% PEG 300+5% Tween 80+ddH2O
For best results, use promptly after mixing.
1mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 413.49
Formula

C25H19NO3S

CAS No. 503468-95-9
Storage powder
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    Previous aliquots were clear and colorless while this time, it becomes yellow when the powder was dissolved in DMSO? Could you advice on this?

  • Answer:

    Slight color variation due to different processing is normal and usually doesn't interfere with the function.

Related Antibodies

DNA-PK Signaling Pathway Map

DNA-PK Inhibitors with Unique Features

Related DNA-PK Products

Tags: buy NU7441 (KU-57788) | NU7441 (KU-57788) supplier | purchase NU7441 (KU-57788) | NU7441 (KU-57788) cost | NU7441 (KU-57788) manufacturer | order NU7441 (KU-57788) | NU7441 (KU-57788) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID